Home Cart Sign in  
Chemical Structure| 1775-97-9 Chemical Structure| 1775-97-9

Structure of Flavokavain B
CAS No.: 1775-97-9

Chemical Structure| 1775-97-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Flavokawain B is an effective apoptosis inducer that inhibits the growth of various cancer cell lines. Flavokawain B has strong anti-angiogenic activity and inhibits the migration and tube formation of human brain endothelial cells (HUVECs) at extremely low non-toxic concentrations.

Synonyms: Flavokawain B

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Flavokavain B

CAS No. :1775-97-9
Formula : C17H16O4
M.W : 284.31
SMILES Code : O=C(C1=C(OC)C=C(OC)C=C1O)/C=C/C2=CC=CC=C2
Synonyms :
Flavokawain B
MDL No. :MFCD00075877
InChI Key :QKQLSQLKXBHUSO-CMDGGOBGSA-N
Pubchem ID :5356121

Safety of Flavokavain B

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MKN45 cells 1.25–5 µg/mL 24 hours FKB combined with doxorubicin showed synergistic growth inhibition in MKN45 cells. Cancers (Basel). 2020 Sep 1;12(9):2475
SCM-1 cells 1.25–5 µg/mL 24 hours FKB combined with doxorubicin showed synergistic growth inhibition in SCM-1 cells. Cancers (Basel). 2020 Sep 1;12(9):2475
AGS cells 1.25–5 µg/mL 24 hours FKB combined with doxorubicin significantly suppressed AGS cell growth, induced DNA fragmentation, apoptotic cell death, and autophagy. Cancers (Basel). 2020 Sep 1;12(9):2475
P3 cells 3 μg/mL 48 hours Evaluate the inhibitory effect of FKB on GBM cell proliferation, results showed FKB significantly inhibited cell proliferation. Autophagy. 2018;14(11):2007-2022
T98 cells 3 μg/mL 48 hours Evaluate the inhibitory effect of FKB on GBM cell proliferation, results showed FKB significantly inhibited cell proliferation. Autophagy. 2018;14(11):2007-2022
U87 cells 3 μg/mL 48 hours Evaluate the inhibitory effect of FKB on GBM cell proliferation, results showed FKB significantly inhibited cell proliferation. Autophagy. 2018;14(11):2007-2022
U251 cells 3 μg/mL 48 hours Evaluate the inhibitory effect of FKB on GBM cell proliferation, results showed FKB significantly inhibited cell proliferation. Autophagy. 2018;14(11):2007-2022
TPC-1 cells 6 μg/mL 24 hours To evaluate the effect of FKB on the proliferation of thyroid cancer cells, results showed that FKB significantly inhibited the proliferation of TPC-1 cells. Cancer Sci. 2018 Aug;109(8):2576-2589
WRO cells 6 μg/mL 24 hours To evaluate the effect of FKB on the proliferation of thyroid cancer cells, results showed that FKB significantly inhibited the proliferation of WRO cells. Cancer Sci. 2018 Aug;109(8):2576-2589
ARO cells 6 μg/mL 24 hours To evaluate the effect of FKB on the proliferation of thyroid cancer cells, results showed that FKB significantly inhibited the proliferation of ARO cells. Cancer Sci. 2018 Aug;109(8):2576-2589
LNCaP cells 8.8 μM 24 hours FKB inhibits Cullin-1 neddylation Cell Commun Signal. 2019 Mar 18;17(1):25
C4-2B cells 8.8 μM 24 hours FKB downregulated Skp2 protein expression and increased p27/Kip1 expression Cell Commun Signal. 2019 Mar 18;17(1):25
DU145 cells 8.8 μM 16 hours FKB confirmed inhibition of Cullin-1 neddylation via immunoprecipitation Cell Commun Signal. 2019 Mar 18;17(1):25
PC3 cells 8.8 μM 24 hours FKB inhibits neddylation of Cullin-1 and Ubc12, leading to Skp2 degradation and increased p27/Kip1 expression Cell Commun Signal. 2019 Mar 18;17(1):25
MDA-MB-231 5.90 ± 0.30 µg/mL 72 hours To evaluate the cytotoxic effects of FKB and its derivatives on MDA-MB-231 cells, results showed that FKB has potential cytotoxicity. Molecules. 2018 Mar 8;23(3):616
MCF-7 7.70 ± 0.30 µg/mL 72 hours To evaluate the cytotoxic effects of FKB and its derivatives on MCF-7 cells, results showed that FKB has potential cytotoxicity. Molecules. 2018 Mar 8;23(3):616
B16/F10 melanoma cells 25 µM 72 hours To evaluate cell viability and melanin content, results showed FLB at 25 µM significantly reduced melanin content (9.6-fold decrement) and tyrosinase activity (9-fold decrement). Molecules. 2020 Jul 28;25(15):3403

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice AGS cell xenograft model Intraperitoneal injection 0.5 or 0.75 mg/kg Every two days for 36 days FKB combined with doxorubicin significantly inhibited the growth of AGS xenografts in nude mice. Cancers (Basel). 2020 Sep 1;12(9):2475
Athymic nude mice Intracranial tumor model Intraperitoneal injection 50 mg/kg/day Every other day starting on day 3 following implantation Evaluate the inhibitory effect of FKB on GBM tumor growth, results showed FKB significantly inhibited tumor growth and prolonged survival time. Autophagy. 2018;14(11):2007-2022
Athymic mice WRO cell subcutaneous xenograft model Subcutaneous injection 50 mg/kg/day Every other day for 18 days To evaluate the effect of FKB on the growth of thyroid cancer xenografts, results showed that FKB significantly inhibited tumor growth. Cancer Sci. 2018 Aug;109(8):2576-2589
C57BL/6 mice LPS-induced acute lung injury (ALI) model Intragastric administration 10 mg/kg and 20 mg/kg Once daily for 3 consecutive days To evaluate the protective effect of FKB against LPS-induced ALI. Results showed FKB pretreatment significantly reduced lung tissue inflammatory cell infiltration, alveolar wall thickening, and lung injury scores, decreased total cell and neutrophil counts in BALF, and reduced MPO activity in lung tissues. Acta Pharmacol Sin. 2022 Jul;43(7):1758-1768
Zebrafish (Danio rerio) Zebrafish embryo model Dissolved in embryo media 6.25 µM From 9 hpf to 144 hpf To assess toxicity and melanogenesis inhibition, results showed FLB at 6.25 μM was non-toxic and effectively inhibited melanogenesis. Molecules. 2020 Jul 28;25(15):3403

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.52mL

0.70mL

0.35mL

17.59mL

3.52mL

1.76mL

35.17mL

7.03mL

3.52mL

 

Historical Records

Categories